|
|
||||||||
Technical Briefs |
1 Division of Endocrinology, Department of Medicine, and 2 Department of Epidemiology and Biostatistics, University of California, San Francisco, 74 New Montgomery St., Suite 600, San Francisco, CA 94105
aauthor for correspondence: fax 415-597-9213, e-mail dantoniucci@psg.ucsf.edu
| The first 20% of the full text of this article appears below. |
Vitamin D deficiency is a common disorder believed to affect as many as 57% of hospitalized patients (1) and 950% of outpatients, depending on the characteristics of the study population (2)(3)(4)(5)(6). Vitamin D deficiency can cause secondary hyperparathyroidism and, if severe, osteomalacia. Both of these conditions are associated with loss of bone density, and both are reversible by repletion of vitamin D (7)(8)(9)(10). Recently, the association of vitamin D deficiency with an increased risk for a broader range of diseases, such as prostate cancer (11)(12) and colon cancer(13), has come to attention. Dietary vitamin D supplementation has even been implicated in decreasing the risk of developing type 1 diabetes mellitus (14), and ultraviolet irradiation has been shown to decrease systolic blood pressure in patients with mild untreated hypertension (15). Determining whether vitamin D deficiency is present usually involves assessing the stores of vitamin D by measuring serum 25-hydroxyvitamin D (25OHD) concentrations, in combination with an assessment of parathyroid hormone concentrations. Currently, the preferred clinical 25OHD assay is a two-step procedure
The following articles in journals at HighWire Press have cited this article:
![]() |
S. Mark, K. Gray-Donald, E. E. Delvin, J. O'Loughlin, G. Paradis, E. Levy, and M. Lambert Low Vitamin D Status in a Representative Sample of Youth From Quebec, Canada Clin. Chem., August 1, 2008; 54(8): 1283 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L Neuhouser, B. Sorensen, B. W Hollis, A. Ambs, C. M Ulrich, A. McTiernan, L. Bernstein, S. Wayne, F. Gilliland, K. Baumgartner, et al. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors Am. J. Clinical Nutrition, July 1, 2008; 88(1): 133 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hypponen, S. Turner, P. Cumberland, C. Power, and I. Gibb Serum 25-Hydroxyvitamin D Measurement in a Large Population Survey with Statistical Harmonization of Assay Variation to an International Standard J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4615 - 4622. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tuohimaa, L. Tenkanen, H. Syvala, S. Lumme, T. Hakulinen, J. Dillner, and M. Hakama Interaction of Factors Related to the Metabolic Syndrome and Vitamin D on Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 302 - 307. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |